Literature DB >> 7780077

Drug management for coronary revascularization without cardiac standstill: the use of high-dose esmolol.

D C Abramson1, E G Pivalizza, L I Gottschalk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7780077     DOI： 10.1016/S1053-0770(05)80193-4

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN： 1053-0770            Impact factor:   2.628


× No keyword cloud information.
  4 in total

1.  The effects of a new ultra-short-acting beta-adrenergic blocker, ONO-1101, on cardiac function during and after cardiopulmonary bypass.

Authors:  I Ahmet; N Fukushima; Y Sawa; T Masai; K Kadoba; K Kagisaki; J C Chang; T Yamaguchi; H Matsuda
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

Review 2.  Clinical pharmacokinetics and therapeutic efficacy of esmolol.

Authors:  Donald B Wiest; Jason S Haney
Journal:  Clin Pharmacokinet       Date:  2012-06-01       Impact factor: 6.447

3.  The effect of landiolol on cerebral blood flow in patients undergoing off-pump coronary artery bypass surgery.

Authors:  Koji Goto; Satoshi Hagiwara; Seigo Hidaka; Shunsuke Yamamoto; Junya Kusaka; Norihisa Yasuda; Chihiro Shingu; Takayuki Noguchi
Journal:  J Anesth       Date:  2010-01-06       Impact factor: 2.078

Review 4.  Anesthetic challenges in minimally invasive cardiac surgery: Are we moving in a right direction?

Authors:  Vishwas Malik; Ajay Kumar Jha; Poonam Malhotra Kapoor
Journal:  Ann Card Anaesth       Date:  2016 Jul-Sep
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.